The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patients.

Bianka MarkleinMadeleine JenningZoltán KonthurThomas HäuplFranziska WelzelUte NonhoffSylvia KrobitschDebbie M MulderMarije I KoendersVijay JoshuaAndrew P CopeMark J ShlomchikHans-Joachim AndersGerd R BurmesterAase HensvoldAnca I CatrinaJohan RönnelidGünter SteinerKarl Skriner

Published in: Arthritis research & therapy (2021)

CNDL-index defines people at risk to develop RA and the "window of treatment success" thereby closing the sensitivity gap in RA.

Keyphrases

rheumatoid arthritis
end stage renal disease
disease activity
chronic kidney disease
ejection fraction
newly diagnosed
systemic lupus erythematosus
replacement therapy
systemic sclerosis
idiopathic pulmonary fibrosis